Welcome to Grant for Multiple Sclerosis Innovation (GMSI)


Grant for Multiple Sclerosis Innovation

The four award winners of the first Grant for Multiple Sclerosis Innovation (GMSI) were announced during the satellite symposium at the 29th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, on Saturday 5 October 2013. The opening of the second GMSI was also announced during this symposium.

The submission deadline for applications for the 2014 grant has now passed. The 2015 grant will be open for applications following ECTRIMS 2014 and will close on 16 March 2015.

The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.